CAMBRIDGE, Mass. — Iterative Health has acquired three cardiology sites from NextStage Clinical Research, expanding the Cambridge-based company’s cardiovascular clinical research capabilities.
The sites are located in Beaumont, Port Arthur and Waco, Texas. Iterative Health said the locations bring experienced research teams, established relationships with community-based provider groups and an active portfolio of cardiology trials.
The acquisition expands Iterative Health’s site network into a major therapeutic area as cardiovascular disease continues to affect a large share of U.S. adults. The company said its model is focused on embedding clinical research in community care settings, giving patients access to investigational therapies and devices while helping biopharma and medical device sponsors reach patient populations that reflect real-world communities.
“Joining Iterative Health is a natural next step for our site staff and the patients we serve,” said Donald S. Cross, MD, MHCDS, FACC, cardiologist and principal investigator at Waco Cardiology Associates. “Their network gives us the operational backbone and global reach to expand our impact, reach more patients across Texas, and contribute to cardiovascular research at a scale worthy of the patients who trust us with their care.”
Iterative Health said the newly acquired sites build on its existing work across gastroenterology, hepatology and obesity. The company said its 250-person team supports clinical, regulatory, financial and operational functions across its network.
The company also uses proprietary AI and engineering tools to support patient recruitment, improve efficiency and advance trial design. Iterative Health said it now has more than 100 sites on three continents.
“These established sites are a key addition as we build out our cardiology focus within Iterative Health’s global network,” said Jonathan Ng, founder and CEO of Iterative Health. “They bring experienced teams with deep community trust and a shared understanding that embedding research in those settings is how you advance both access and outcomes. That shared belief is what makes this the right fit, and we look forward to the impact these sites will contribute as part of our growing cardiology network.”
